trial · primary record
Cyproterone Acetate 2 mg and Ethinyl Estradiol 0.02 mg
Contraception
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 1600 |
| Primary completion | 2030-05-31 |
| Primary endpoint | Contraceptive Efficacy Assessed by Pearl Index in Participants Aged ≤35 Years |
| Registry ID | NCT07714616 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:41.098Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07714616
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.